BioMar Group A/S (BIOMAR) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of BioMar Group A/S stock DKK 121, price DKK 128, upside -5.1%, quality 70 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 27, 2026.
How to read this chart
5‑month range kr 105.00 – kr 134.40 · fair‑value band kr 90.82 – kr 162.97 · the kr 127.60 price screens above the kr 121.10 fair value. As of Oct 27, 2026.
Follow BioMar Group A/S in your weekly email
Every Wednesday you see whether BioMar Group A/S is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
BioMar Group A/S provides feeding solutions in the aquaculture industry in Denmark. It operates through four segments: Salmon, Shrimp, Selected Species, and Tech Solutions.
Show moreShow less
The company develops, produces, and delivers feeding solutions for species, such as salmon, shrimp, sea bass, sea bream, trout, turbot, and sturgeon to farmers. It also offers aquaculture feed solutions for Atlantic and Pacific salmon, warm-water shrimp, and other special species.
In addition, the company provides AI-based technology solutions for aquacultural feeding and farming. BioMar Group A/S was formerly known as Dansk Ørredfoder A/S and changed its name to BioMar Group A/S in 1994. The company was incorporated in 1962 and is based in Aarhus, Denmark.
BioMar Group A/S operates as a subsidiary of Aktieselskabet Schouw & Co.
Stock analysis
BioMar Group A/S (BIOMAR) currently trades at kr 127.60, while our model-based Fair Value estimate is kr 121.10, so the stock looks roughly fairly valued today (gap 5.4%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of kr 148.77 per share, and 9 of the 20 models we run sit above the kr 127.60 price.
Bear case: the Asset-Based group reads lowest at kr 12.73, and 11 of the 20 models stay below the price. Data coverage for this calculation is high.
Scenario range: kr 90.82 (bear) to kr 162.97 (bull), the price of kr 127.60 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
BioMar Group A/S reported revenue of 16.5B DKK in FY2025 versus 17.9B DKK in FY2023, a compound −3.8%/yr. Reported net income was 714M DKK in FY2025, compounding +24.5%/yr from FY2023.
Key figures
Market cap 12.8B DKK (≈ $1.9B) Small · P/E ratio 18.2 · P/S ratio 0.77 · EPS (TTM) kr 7.01 · Dividend yield 5.5% · Net margin 4.2% · Return on assets (EBIT) 9.4% · Operating margin 14.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (medium confidence).
What moves the price
For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −5%, BIOMAR screens richer than that median.
Fair Value models
Bearkr 90.82Fair Value kr 121.10Bullkr 162.97
Price kr 127.60 · Upside -5.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 5.80 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
Price in line with expectations
The price assumes more growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (Denmark: IMF forecast 2.1% a year to 2030, 2.0% from 2016 to 2025) that is about +1.3% a year for the price and +3.6% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 288 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside−5.1% · Below median
Profitability
Return on assets6.4% · Top 25%
Net margin (12 months)4.2% · Above median
Operating margin (12 months)14.5% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)67.6% · Top 25%
Dividend yield (12 months)5.5% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Farm Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "BioMar Group A/S Fair Value". https://www.fairvalue-calculator.com/stock/BIOMAR
Frequently asked questions
Is BioMar Group A/S (BIOMAR) overvalued or undervalued?
As of Oct 27, 2026, our model estimates a fair value of kr 121.10 versus a price of kr 127.60, about −5% upside (fairly valued).
What is the fair value of BIOMAR?
Our model-based fair value for BioMar Group A/S is kr 121.10 (as of Oct 27, 2026), built from audited fundamentals. The current price: kr 127.60.
What is the quality score of BIOMAR?
BioMar Group A/S has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BioMar Group A/S (BIOMAR)?
Our model-based price target is the fair value of kr 121.10 (as of Oct 27, 2026) from 20 valuation models. Cautious scenario kr 90.82, optimistic scenario kr 162.97. It is a calculation from audited fundamentals, not an analyst target.
What is the BioMar Group A/S stock forecast for 2026?
Our models put fair value at kr 121.10, about −5% upside versus a price of kr 127.60 (fairly valued). Cautious scenario kr 90.82, optimistic scenario kr 162.97. The calculation is refreshed regularly with new filings.
What is the revenue of BioMar Group A/S (BIOMAR)?
BioMar Group A/S reported trailing-twelve-month revenue of about 16.7B DKK (latest available figure, as of Oct 27, 2026).
Does BioMar Group A/S pay a dividend?
BioMar Group A/S currently shows a dividend yield of 5.52% relative to its recent price (as of Oct 27, 2026).
What growth is priced into BioMar Group A/S (BIOMAR)?
For today's price to be fair in a discounted-cash-flow model, BioMar Group A/S would have to grow free cash flow by +3.4 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew -3.8 % per year. As of Oct 27, 2026.
What discount rate (WACC) does the fair value of BIOMAR use?
Our models discount BioMar Group A/S at 11.0 %: a base by market capitalisation (small), country premium for Denmark. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For BioMar Group A/S that is +3.4 % per year a year over ten years, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has BioMar Group A/S (BIOMAR) delivered so far?
Over the past 2 years revenue at BioMar Group A/S grew -3.8 % a year. The price currently implies +3.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of BioMar Group A/S (BIOMAR) growing?
The median revenue growth in the sector is +1.3 % a year. That is the yardstick for the growth priced into BioMar Group A/S (+3.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of BioMar Group A/S (BIOMAR)?
The free-cash-flow yield on the price is 10.01 %: that much free cash flow BioMar Group A/S produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of BioMar Group A/S (BIOMAR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BioMar Group A/S it is kr 121.10 per share (as of Oct 27, 2026), against a price of kr 127.60. It is the blended result of 20 valuation models (cash flow, earnings, asset, dividend).
Is BioMar Group A/S stock overvalued or undervalued in 2026?
As of Oct 27, 2026, BIOMAR trades above its calculated fair value: price kr 127.60, fair value kr 121.10, a gap of about −5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BIOMAR?
No. The price is what the market pays today (kr 127.60); the fair value is what the company's own numbers justify (kr 121.10). For BioMar Group A/S the two are kr 6.50 per share apart. That gap is exactly why we show both numbers side by side.
How much is BioMar Group A/S worth?
The market values BioMar Group A/S at about 12.8B DKK (market capitalisation, as of Oct 27, 2026). Per share that is kr 127.60; our models calculate a fair value of kr 121.10 per share.
What do the bullish and bearish scenarios say about BIOMAR?
Our models span a range for BioMar Group A/S: cautious scenario kr 90.82, base kr 121.10, optimistic kr 162.97 per share (as of Oct 27, 2026, price kr 127.60). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BIOMAR?
BioMar Group A/S trades at a price-to-earnings ratio of 18.2 (as of Oct 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 121.10 is built from several models across several years. Other multiples: P/B 4.0, P/S 0.8, EV/EBITDA 7.0.
How solid is the balance sheet of BioMar Group A/S (BIOMAR)?
Balance-sheet figures for BioMar Group A/S (as of Oct 27, 2026): debt of 0.01 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
Which stocks are comparable to BioMar Group A/S?
From the same area (Consumer Defensive) we also value Archer-Daniels-Midland Company, Muyuan Foods Group, Bunge Global SA, Tyson Foods, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BioMar Group A/S stock attractive at the current price?
The data as of Oct 27, 2026: price kr 127.60, calculated fair value kr 121.10 (−5%), Quality Score 70/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BIOMAR calculated?
We run BioMar Group A/S through 20 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 121.10, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. BioMar Group A/S itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BioMar Group A/S (BIOMAR)?
The closing price on Oct 28, 2026 was kr 127.60. Our model-based fair value is kr 121.10, about −5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BioMar Group A/S right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Key figures of BioMar Group A/S
How large is the market capitalisation of BioMar Group A/S (BIOMAR)?
The market capitalisation of BioMar Group A/S is 12.8B DKK (≈ $1.9B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BioMar Group A/S (BIOMAR)?
The price-to-sales ratio of BioMar Group A/S is 0.77 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of BioMar Group A/S (BIOMAR)?
Earnings per share at BioMar Group A/S are kr 7.01 (price ÷ EPS = P/E 18.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of BioMar Group A/S (BIOMAR)?
The dividend yield of BioMar Group A/S is 5.5% (payout 100%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of BioMar Group A/S (BIOMAR)?
The net margin of BioMar Group A/S is 4.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of BioMar Group A/S (BIOMAR)?
On an EBIT basis the return on assets of BioMar Group A/S is 9.4% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BioMar Group A/S (BIOMAR)?
The operating margin of BioMar Group A/S is 14.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BioMar Group A/S (BIOMAR)?
Revenue at BioMar Group A/S is growing +67.6% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at BioMar Group A/S (BIOMAR)?
Earnings per share at BioMar Group A/S are growing −3.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does BioMar Group A/S (BIOMAR) carry?
The net debt of BioMar Group A/S is 2.8B DKK (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch BioMar Group A/S in the live analysis
One click puts BioMar Group A/S on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 27, 2026